ā”Favipiravir Drug Gets Approval For Clinical Trials From CSIR As a Potential Vaccine Against COVID-19
By Team Latestly
Drug Controller General of India has given approval for clinical trials of Favipiravir. CSIR Director General Shekhar Mande said the drug which is used in influenza in Japan, China, could be potentially useful against coronavirus.